Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults [Phase 4]

View source ↗

Summary

A Phase 4 trial to evaluate the safety and efficacy of switching from a calcineurin inhibitor to everolimus in adult kidney transplant recipients. The study foc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• CYCLOSPORINE (cyclosporine)
• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Deise de Boni Monteiro de Carvalho | Conditions: Kidney Transplant, Immunosuppression | Phase 4 | Status: UNKNOWN